Alessio Fiascarelli

3PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 13, 2023
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.

Alessio Fiascarelli, Giuseppe Merlino, Stefania Capano

|Jun 23, 2019
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors.

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni

Pageof 1